Risk and timing of cardiovascular death among patients with myelodysplastic syndromes

Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders associated with progression to leukemia and poor survival. Clonal hematopoiesis in people without an MDS diagnosis carries an increased risk of cardiovascular death. Many clonally restricted mutations are shared between pat...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Blood Adv
Prif Awduron: Brunner, Andrew M., Blonquist, Traci M., Hobbs, Gabriela S., Amrein, Philip C., Neuberg, Donna S., Steensma, David P., Abel, Gregory A., Fathi, Amir T.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Hematology 2017
Pynciau:
Myeloid Neoplasia
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728287/
https://ncbi.nlm.nih.gov/pubmed/29296849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017010165
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg